183 related articles for article (PubMed ID: 37789421)
1. Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis.
Nousiainen S; Kuismin O; Reinikka S; Manninen R; Khamaiseh S; Kuivalainen M; Terho A; Koivurova S; Niinimäki M; Salokas K; Varjosalo M; Ahtikoski A; Bützow R; Lindgren O; Uimari O; Vahteristo P
Hum Genomics; 2023 Oct; 17(1):88. PubMed ID: 37789421
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing reveals novel candidate variants for endometriosis utilizing multiple affected members in a single family.
Kina BG; Topbas Selcuki NF; Bahat PY; Usta T; Aydin S; Rahmioglu N; Tuncer FN; Oral E
Mol Genet Genomic Med; 2024 Jan; 12(1):e2312. PubMed ID: 38013616
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.
Subramanian DN; Zethoven M; McInerny S; Morgan JA; Rowley SM; Lee JEA; Li N; Gorringe KL; James PA; Campbell IG
Nat Commun; 2020 Apr; 11(1):1640. PubMed ID: 32242007
[TBL] [Abstract][Full Text] [Related]
4. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Lu Y; Cuellar-Partida G; Painter JN; Nyholt DR; ; ; Morris AP; Fasching PA; Hein A; Burghaus S; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Vanderstichele A; Doherty JA; Rossing MA; Wicklund KG; Chang-Claude J; Eilber U; Rudolph A; Wang-Gohrke S; Goodman MT; Bogdanova N; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Antonenkova N; Butzow R; Leminen A; Nevanlinna H; Pelttari LM; Edwards RP; Kelley JL; Modugno F; Moysich KB; Ness RB; Cannioto R; Høgdall E; Jensen A; Giles GG; Bruinsma F; Kjaer SK; Hildebrandt MA; Liang D; Lu KH; Wu X; Bisogna M; Dao F; Levine DA; Cramer DW; Terry KL; Tworoger SS; Missmer S; Bjorge L; Salvesen HB; Kopperud RK; Bischof K; Aben KK; Kiemeney LA; Massuger LF; Brooks-Wilson A; Olson SH; McGuire V; Rothstein JH; Sieh W; Whittemore AS; Cook LS; Le ND; Gilks CB; Gronwald J; Jakubowska A; Lubiński J; Gawełko J; Song H; Tyrer JP; Wentzensen N; Brinton L; Trabert B; Lissowska J; Mclaughlin JR; Narod SA; Phelan C; Anton-Culver H; Ziogas A; Eccles D; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Wu AH; Dansonka-Mieszkowska A; Kupryjanczyk J; Timorek A; Szafron L; Cunningham JM; Fridley BL; Winham SJ; Bandera EV; Poole EM; Morgan TK; Risch HA; Goode EL; Schildkraut JM; Webb PM; Pearce CL; Berchuck A; Pharoah PD; Montgomery GW; Zondervan KT; Chenevix-Trench G; MacGregor S
Hum Mol Genet; 2015 Oct; 24(20):5955-64. PubMed ID: 26231222
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing and functional validation reveal a rare missense variant in MMP7 that confers ovarian endometriosis risk.
Liu F; Zhou J; Zhang X; Fang S; Liu R; Chen G; Luo Y; Zhang Z; Cheng Y; Wang L; Guo J; Zou Y
Hum Mol Genet; 2022 Aug; 31(15):2595-2605. PubMed ID: 35288736
[TBL] [Abstract][Full Text] [Related]
7. [Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández VM
Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
[TBL] [Abstract][Full Text] [Related]
8. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
9. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
Mortlock S; Corona RI; Kho PF; Pharoah P; Seo JH; Freedman ML; Gayther SA; Siedhoff MT; Rogers PAW; Leuchter R; Walsh CS; Cass I; Karlan BY; Rimel BJ; ; Montgomery GW; Lawrenson K; Kar SP
Cell Rep Med; 2022 Mar; 3(3):100542. PubMed ID: 35492879
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing identifies hemizygous deletions in the UGT2B28 and USP17L2 genes in a three‑generation family with endometriosis.
Albertsen HM; Matalliotaki C; Matalliotakis M; Zervou MI; Matalliotakis I; Spandidos DA; Chettier R; Ward K; Goulielmos GN
Mol Med Rep; 2019 Mar; 19(3):1716-1720. PubMed ID: 30628680
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.
Hirvonen EAM; Pitkänen E; Hemminki K; Aaltonen LA; Kilpivaara O
Hum Genomics; 2017 Apr; 11(1):6. PubMed ID: 28427458
[TBL] [Abstract][Full Text] [Related]
12. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
13. [Endometriosis-related ovarian tumors].
Schmidt D; Ulrich U
Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.
Wu RC; Veras E; Lin J; Gerry E; Bahadirli-Talbott A; Baras A; Ayhan A; Shih IM; Wang TL
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162652
[TBL] [Abstract][Full Text] [Related]
15. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
16. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
[TBL] [Abstract][Full Text] [Related]
17. Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
Stafford JL; Dyson G; Levin NK; Chaudhry S; Rosati R; Kalpage H; Wernette C; Petrucelli N; Simon MS; Tainsky MA
PLoS One; 2017; 12(6):e0178450. PubMed ID: 28591191
[TBL] [Abstract][Full Text] [Related]
18. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
Suda K; Cruz Diaz LA; Yoshihara K; Nakaoka H; Yachida N; Motoyama T; Inoue I; Enomoto T
Cancer Sci; 2020 Aug; 111(8):3000-3009. PubMed ID: 32473611
[TBL] [Abstract][Full Text] [Related]
19. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Fierheller CT; Guitton-Sert L; Alenezi WM; Revil T; Oros KK; Gao Y; Bedard K; Arcand SL; Serruya C; Behl S; Meunier L; Fleury H; Fewings E; Subramanian DN; Nadaf J; Bruce JP; Bell R; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Majewski J; Pugh TJ; Tischkowitz M; James PA; Campbell IG; Greenwood CMT; Ragoussis J; Masson JY; Tonin PN
Genome Med; 2021 Dec; 13(1):186. PubMed ID: 34861889
[TBL] [Abstract][Full Text] [Related]
20. Molecular Genetic Characteristics of
Fierheller CT; Alenezi WM; Serruya C; Revil T; Amuzu S; Bedard K; Subramanian DN; Fewings E; Bruce JP; Prokopec S; Bouchard L; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Tischkowitz M; Campbell IG; Pugh TJ; Greenwood CMT; Ragoussis J; Tonin PN
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
